Disease control with prior platinum-based chemotherapy is prognostic for survival in patients with metastatic urothelial cancer treated with atezolizumab in real-world practice

URN:NBN:SI:doc-5TI62RTT2021Bokal, UrškaMangaroski, DushanMencinger, Marinadocuments/doc/5/URN_NBN_SI_doc-5TI62RTT_001.pdfdocuments/doc/5/URN_NBN_SI_doc-5TI62RTT_001.txt455articlestr. 491-498, XII10.2478/raon-2021-00211318-209992836867URN:NBN:SI:doc-5TI62RTTengCroatian Medical Association - Croatian Society of RadiologySlovenian Medical Society - Section of RadiologyRadiology and oncology (Ljubljana)BYatezolizumabbladderkemoterapijaPD-L1 inhibitorrak (medicina)sečilaurothelial cancerzaviralec PD-L1zdravljenjeDisease control with prior platinum-based chemotherapy is prognostic for survival in patients with metastatic urothelial cancer treated with atezolizumab in real-world practice